10-K: National Vision Reports Strong 2025 Growth, Strategic Transformation Underway

National Vision Holdings, Inc. reported a significant turnaround in fiscal year 2025, achieving net income from continuing operations of $29.6 million and 9.0% net revenue growth, driven by strategic initiatives and improved comparable store sales.

Summary

• Net revenue for fiscal year 2025 increased by 9.0% to $1,987.5 million, up from $1,823.3 million in fiscal year 2024.
• Income from continuing operations reached $29.6 million in fiscal year 2025, a substantial improvement from a loss of $27.2 million in fiscal year 2024.
• Adjusted Comparable Store Sales Growth from continuing operations was 6.0% in fiscal year 2025, primarily due to higher average ticket and strength in the managed care segment.
• The company opened 33 new stores in fiscal year 2025, primarily Americas Best locations, and plans to open 30 to 35 new stores in fiscal year 2026.
• Strategic transformation initiatives, including brand refreshes for National Vision and Americas Best, updated marketing, new in-store technologies, and pricing architecture, are focused on accelerating long-term growth and strengthening profitability.
• Remote telehealth capabilities are now installed in over 800 locations, enhancing patient care access and addressing optometrist availability constraints.
• Managed care business represented 42% of revenues from continuing operations in fiscal year 2025, with a goal to reach 50%.
• The company fully repaid the remaining $84.8 million principal balance of its 2025 Notes in May 2025.
• A new share repurchase authorization of up to $50 million was approved by the Board of Directors, effective March 2, 2026, until December 28, 2030.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, reflecting a significant financial turnaround, robust revenue growth, and successful implementation of strategic initiatives, despite ongoing industry challenges like wage pressure and customer traffic.

Positives

• Net income from continuing operations significantly improved to $29.6 million in fiscal year 2025, compared to a loss of $27.2 million in fiscal year 2024.
• Total net revenue increased by 9.0% to $1,987.5 million in fiscal year 2025, demonstrating strong top-line growth.
• Adjusted Comparable Store Sales Growth of 6.0% in fiscal year 2025 indicates healthy performance in existing stores, driven by higher average ticket and managed care strength.
• Costs applicable to revenue as a percentage of net revenue decreased by 70 basis points, primarily due to successful execution of pricing and product mix initiatives in eyeglasses.
• SG&A as a percentage of net revenue decreased by 40 basis points, driven by improved leverage of advertising investments and other expenses.
• The company successfully implemented remote telehealth capabilities in over 800 locations, improving access to patient care and exam capacity.
• Full repayment of the remaining $84.8 million principal balance of the 2025 Notes in May 2025 strengthens the balance sheet.
• The Board authorized a new $50 million share repurchase program, signaling confidence in future cash flow and commitment to shareholder returns.
• The company entered into an interest rate swap to mitigate variability in term loan interest payments, enhancing financial stability.

Negatives

• Customer traffic experienced a slight decrease in fiscal year 2025, partially offsetting gains from higher average ticket.
• Costs of services and plans as a percentage of net sales of services and plans increased by 170 basis points, driven by lower growth in add-ons and eye exam revenues relative to optometrist-related costs.
• Higher healthcare expenses partially offset the leverage gained from advertising investments and other expenses in SG&A.
• Wage pressure for vision care professionals and associates continued in 2025 and is expected to persist into 2026, increasing operating costs.
• Remote medicine and EHR platforms, while increasing capacity, have resulted in higher costs applicable to revenue as a percentage of revenue compared to in-store exams.
• The company experienced an increased degree of vision care professional shortages and related exam capacity constraints in 2025, which may continue into 2026 and beyond.
• Unearned and deferred revenue negatively impacted net revenue by $13.8 million in fiscal year 2025 compared to fiscal year 2024, primarily due to timing of recognition.

Risks

• Market volatility, economic downturns, and global macroeconomic conditions could affect consumer spending and behavior, harming sales and profitability.
• Failure to successfully implement strategic initiatives or anticipate their impact could adversely affect business and financial results.
• The optical retail industry is highly competitive, and an inability to compete successfully could materially impact the business.
• Failure to maintain, protect, and enhance the value of owned brands (Americas Best, Eyeglass World) could negatively impact financial condition and results of operations.
• Unsuccessful or inefficient marketing, advertising, and promotional efforts, or more effective competitor strategies, could materially adversely affect the business.
• Failure to open and operate new stores in a timely and cost-effective manner or to successfully enter new markets could materially adversely affect financial performance.
• Growth is dependent on increasing sales in existing stores and successful reinvestment, and failure in these areas could have a material adverse effect.
• Inability to successfully implement pricing strategies could lead to decreased sales and market share.
• Failure to recruit and retain vision care professionals for in-store roles or to provide remote care offerings could adversely affect the business.
• Reliance on value-based inputs makes the business susceptible to wage rate increases, inflation, and increases in raw material and energy prices.
• Significant indebtedness could adversely affect business and financial position by limiting flexibility and preventing debt obligations from being met.
• Changes in interest rates may adversely affect the business, particularly due to variable-rate debt.
• Credit agreement restrictions limit flexibility in operating the business, potentially hindering additional financing or strategic opportunities.
• The stock price may be volatile or decline regardless of operating performance due to various market and company-specific factors.
• Dependence on subsidiaries for cash flow to fund operations and expenses, including potential future dividends, poses a risk.
• Anti-takeover provisions in organizational documents could delay or prevent a change of control.
• The Board of Directors is authorized to issue preferred stock without stockholder approval, which could reduce common stock value.
• The certificate of incorporation designates Delaware Court of Chancery as the sole forum for certain stockholder litigation, potentially limiting stockholders' ability to choose a favorable forum.
• If securities or industry analysts stop covering the business or downgrade the stock/sector, the stock price and trading volume could decline.
• Catastrophic events, including changing climate and weather patterns, may cause significant business interruptions and expenditures.
• Technological advances or increased consumer preferences for vision correction alternatives could reduce demand for products.
• Ineffective inventory management could materially adversely affect profitability and cash flows due to obsolescence, shrinkage, or stockouts.
• Dependence on distribution centers and optical laboratories means loss or disruption could adversely affect order fulfillment and product delivery.
• Declining performance of Host brands or inability to maintain/extend operating relationships with Host partners could adversely affect business and require impairment charges.
• Sustainability issues, including those related to climate change, could have a material adverse effect on business, financial condition, and results of operations.
• Future operational success depends on developing, maintaining, and extending relationships with managed vision care companies and other third-party payors.
• Reliance on third-party coverage and reimbursement, including government programs, for an increasing portion of revenues means future reductions could materially adversely affect results.
• Risks associated with vendors and dependence on a limited number of suppliers could impair ability to obtain products or services.
• Ability to source merchandise and services outside the U.S. could be adversely impacted by changes in U.S. or international laws, including tariffs.
• Heavy reliance on information technology systems, and those of vendors, means any significant failure, inadequacy, interruption, or security breach could materially adversely affect the business.
• Extensive state, local, and federal vision care and healthcare laws and regulations, with failure to adhere materially adversely affecting the business.
• Managed vision care laws and regulations, and failure to comply, could have a materially negative impact on the business.
• Rapidly changing and stringent privacy, data security, and data protection laws could subject the company to liabilities.
• Product liability, product recall, or personal injury issues could materially adversely affect the business.
• Failure to comply with laws, regulations, and enforcement activities or changes in legal requirements could materially negatively impact the business.
• Adverse judgments or settlements from legal proceedings could materially adversely affect the business.
• Inability to adequately protect intellectual property could harm brand value and materially adversely affect the business.

Future Outlook

The company anticipates opening approximately 30 to 35 new stores in fiscal year 2026, primarily Americas Best locations, before reaccelerating to approximately 60 new stores per year starting in 2028, aiming for a total of 240 new stores through 2030. Investments in CRM, ERP, and other IT initiatives will continue in 2026. The company expects wage pressures in certain markets to persist to some degree in 2026 and anticipates pressures from raw material price increases to impact costs applicable to revenue. The e-commerce consumer websites are expected to move to a new platform integrated with the new CRM system in fiscal 2026. The Eyeglass World brand is expected to be refreshed later in fiscal 2026. Capital expenditures for fiscal year 2026 are projected to be between $73 million and $78 million, focused on new and existing stores and IT infrastructure. The company expects to fund share repurchases using cash on hand.

Management Comments

• We believe that vision is central to quality of life and that people deserve to see their best to live their best.
• Our mission is to help people by making quality eye care and eyewear more affordable and accessible.
• We believe this differentiator (remote telehealth capabilities) greatly improves our ability to provide consistent access to patient care across our network of stores.
• Our strategy is focused around creating a more joyful consumer experience with refreshed merchandising, updated marketing and brand assets, new in-store technologies to support the customer journey, and an updated pricing architecture, all of which allow us to better serve our existing customers and expand our target consumer demographics.
• The new Americas Best brand promise, 'Every Eye Deserves Better,' better reflects our customer mix.
• These consumer-facing strategies are paired with an increased focus on cost optimization and operating margin expansion, all of which are intended to drive the outcome of a stronger core business and improved operating results.
• We believe that we have tremendous opportunity across four growth vectors where we are under-indexed versus the category: Target Customer Segments, Target Product Categories, Enhanced Customer Experience, and New Store Growth.
• We believe remote medicine not only helps provide quality, accessible eye care to more patients, but also helps address constraints in exam capacity from optometrist availability in store.
• We believe our new CRM system will allow us to build dynamic, omnichannel customer journeys based on individual behaviors and preferences in order to maximize customer engagement and increase customer retention through personalized experiences across our brands.
• We believe these investments, along with maintenance of our existing information technology capabilities, will provide the flexibility and capacity to accommodate our future growth plans.
• We believe that video is a key channel for connecting with our customers.
• We believe that less than 10% of costs applicable to revenue are subject to tariffs on Chinese imports; however, tariff rates are subject to change and have varied over the past few years.

Industry Context

StockSavvy.ai notes that National Vision Holdings operates within a highly fragmented and growing U.S. optical retail industry, estimated at $69.5 billion in 2025. The industry benefits from secular growth trends such as an aging population, increased managed vision care adoption (70% of consumers had coverage in 2025), increased screen usage leading to vision correction needs, consistent replacement cycles for eyewear, a growing focus on health and wellness, and momentum in smart eyewear. The company's strategic focus on value, accessibility, and modernization, including telehealth and enhanced customer experience, positions it to capitalize on these trends. Its competition includes independent optical retailers, mass merchants, warehouse clubs, specialty chains, and online sellers, with some larger, vertically integrated competitors like EssilorLuxottica (also a key supplier) posing a significant challenge.

Comparison to Industry Standards

• The filing states that the U.S. optical retail industry is estimated to be $69.5 billion in 2025, but does not provide specific comparable company financial results or projects for direct benchmarking against National Vision's performance.
• The company's managed care business represented 42% of its revenues from continuing operations in fiscal 2025, while The Vision Council reported approximately 70% of consumers had some form of vision care coverage in 2025. This suggests National Vision is currently underpenetrated in the managed care market relative to the broader industry, indicating a growth opportunity.
• The company mentions competing with 'large national retailers' and 'vertically integrated payors' (some of whom are also suppliers, like EssilorLuxottica), but does not offer specific performance metrics of these competitors for a direct comparison of results.

Management Changes

Corporate Governance

Legal Proceedings

• A California wage and hour class action lawsuit, filed by a former employee in September 2022, was settled for $4.6 million (gross settlement fund) in October 2025, with final court approval granted in July 2025.
• A Securities Class Action, filed in January 2023 alleging violations of the Exchange Act, was dismissed with prejudice by the court in March 2024, and a motion for reconsideration was denied in March 2025, with no appeal filed.
• A stockholder derivative complaint, filed in May 2024 based on the same alleged facts as the Securities Class Action, was dismissed by the court in February 2026, with the plaintiff having 30 days to file an appeal.
• A medical negligence lawsuit in Alabama state court, claiming injury during eye exams, was settled for $1.8 million (net of anticipated insurance recoveries) in October 2025, and the case was dismissed in December 2025.

Related Party Transactions

• The company has long-term contracts with certain key suppliers, including EssilorLuxottica and CooperVision. Under the agreement with EssilorLuxottica, EssilorLuxottica has the sole and exclusive right to supply certain eyeglass lenses to the company through May 2028. During fiscal year 2025, approximately 86% of lens expenditures were from this vendor and approximately 96% of contact lens expenditures were with three vendors (including CooperVision).

Stakeholder Impact

• Shareholders: Positive impact from improved financial performance, increased net income, and a new share repurchase authorization, potentially leading to increased shareholder value. However, stock price volatility remains a risk.
• Employees/Optometrists: Continued wage pressure and increased competition for vision care professionals may lead to higher compensation and benefits, but also ongoing challenges in recruitment and retention. The company's focus on talent development and benefits aims to support employees.
• Customers: Enhanced customer experience through modernized stores, updated marketing, new in-store technologies, and remote telehealth capabilities aims to improve satisfaction and loyalty. Pricing strategies are being adjusted to balance value and profitability.
• Suppliers: Continued reliance on a limited number of key suppliers, particularly for eyeglass lenses and contact lenses, creates concentration risk. The company aims for meaningful, long-lasting relationships.
• Managed Care Payors: The company's ability to maintain and extend relationships with managed vision care companies is crucial for revenue growth, as this segment represents a significant portion of overall revenues.
• Regulatory Bodies: Ongoing compliance with extensive federal, state, and local vision care, healthcare, privacy, and consumer protection laws is critical to avoid sanctions and maintain operations.

Next Steps

• Open approximately 30 to 35 new stores in fiscal year 2026, primarily Americas Best stores.
• Continue to progress CRM, ERP, and other IT initiatives in 2026.
• Move e-commerce consumer websites to a new platform integrated with the new CRM system in fiscal 2026.
• Refresh the Eyeglass World brand later in fiscal 2026 as part of its transformation.
• Reallocate capital to increase investments in enhancing the overall patient and customer experience in existing stores, as new store openings are moderated through fiscal 2026.
• Reaccelerate new store openings to approximately 60 per year beginning 2028, totaling approximately 240 new stores through 2030.
• Continue strategic investments in recruitment and retention initiatives for vision care professionals, including flexible adjusted work schedules.
• Continue implementation of remote medicine technologies, primarily in Americas Best stores, adding select locations where feasible and advantageous.
• Monitor legislative and rulemaking activities for changes in telehealth requirements and work with various stakeholders to educate lawmakers.
• Potentially consider prepayment, refinancing, or issuance of debt, equity, or other securities depending on liquidity levels and capital market conditions.
• Execute share repurchases of up to $50 million common stock until December 28, 2030, using cash on hand.

Key Dates

Recommendation

The company demonstrated a strong financial turnaround in fiscal year 2025, moving from a net loss to significant net income from continuing operations, coupled with robust revenue growth and improved comparable store sales. Strategic initiatives focused on modernization, customer experience, and telehealth are gaining traction and are expected to drive future growth. While challenges like wage pressure and customer traffic shifts exist, the company's proactive measures, including a new share repurchase authorization and debt repayment, indicate sound financial management and a positive outlook. The planned reacceleration of store openings and continued investment in technology further support long-term growth potential, making it an attractive investment.

Keywords

Optical Retail, Eyewear, Contact Lenses, Eye Exams, Managed Vision Care, Telehealth, Retail Growth, SEC Filing, 10-K, National Vision Holdings, EYE, Americas Best, Eyeglass World, Corporate Governance, Financial Performance